Acute reduction of visual acuity and visual field after Pfizer-BioNTech COVID-19 vaccine 2nd dose: a case report.

Luca Spiro SantovitoGraziano Pinna

Published in: Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2021)

Long-term and rare adverse effects of COVID-19 vaccines are unknown. Hence, it is important to report them to improve the safety profile of the vaccines and enhance their use worldwide. Here, we describe a case of acute visual impairment after Pfizer-BioNTech vaccine second dose.

Keyphrases

coronavirus disease
liver failure
sars cov
respiratory failure
drug induced
aortic dissection
hepatitis b virus
emergency department
extracorporeal membrane oxygenation
intensive care unit